Nicotine vaping is likely to cause lung and oral cancers, according to a comprehensive review of more than 100 studies reported by ScienceAlert in the packet.
The review matters because it tries to answer a question that has lingered since vaping became mainstream in the early 2000s: what does nicotine inhaled as aerosol do over time? The article says the researchers focused on e-cigarettes in their own right, avoiding dual users and studies that simply compared vaping to smoking. That design choice is important because it makes the findings more directly about vaping rather than about tobacco smoke.
The evidence cited in the packet falls into three broad groups. Human studies showed biomarkers associated with DNA damage, oxidative stress and inflammation. Animal studies in mice showed lung tumors developing as a direct result of exposure to vape aerosol. Lab analyses identified pathways by which compounds in vape liquid, including known carcinogens, can damage cells. Taken together, those strands are what pushed the authors toward a carcinogenicity warning rather than a neutral watch-and-wait conclusion.
The review also points to case reports of heavy vapers who developed aggressive oral cancers without the usual major risk factors such as smoking or viral infection. Case reports do not prove causation on their own, but they do add urgency when they align with the broader biomarker and animal data. That is why the authors and commentary are warning against treating vaping as harmless simply because long-term population data are still incomplete.
The article makes clear that there are still limits to certainty. We do not yet have the same decades of population-level data that eventually linked cigarettes to lung cancer. The review therefore cannot quantify the exact risk, and the source is careful about that. But the absence of a precise percentage does not mean the evidence is weak. The authors say the signs are strong enough that the field should avoid repeating the mistakes made with smoking.
That comparison to cigarettes is central. Vaping was marketed as a cleaner, safer alternative to smoking, and many users adopted it on that assumption. The review does not deny that history; it says the scientific evidence now available is enough to challenge the assumption that nicotine vaping is benign. In the packet, co-authors Freddy Sitas and Bernard Stewart explicitly warn against giving vaping the benefit of the doubt.
For public health, the article is significant because it moves the discussion from general concern to a more specific warning about cancer risk. The source does not claim every vaper will get cancer, nor does it say the risk is identical to smoking. What it does say is that the direction of evidence is moving toward a serious carcinogenicity concern.
That makes the study less about alarmism than about timing. Researchers are saying the evidence base is now strong enough to justify caution before the long-term harm picture fully matures. In that sense, the review is a warning shot: the health debate over vaping is no longer just about addiction and respiratory irritation, but about the possibility of cancer itself.
